4 years ago

QnAs with Carlos Taboada

QnAs with Carlos Taboada
Tinsley H. Davis
A molecule that would be toxic to most animals provides the characteristic blue-green color of hundreds of frog species. In a recent PNAS article (1), biologist Carlos Taboada reports how the typically toxic pigment biliverdin binds to members of a family of serpin proteins to produce a pathway for green coloration in frogs. Taboada is a postdoctoral fellow in biology at Duke University and has been working with frogs since his undergraduate days in Argentina, shifting focus from studies of anatomy and histology to biochemistry and engineering. Taboada discusses the findings from his PNAS article. Carlos Taboada. Image credit: Laura Andrade (photographer). > PNAS:To the human eye, the frogs you studied appear green. How are they different? > Taboada:Most green animals—chameleons, lizards, geckoes, [and] many frogs and salamanders, too—have chromatophore cells. In those animals, all of the color that we see comes from that really thin layer of cells. > > In the species that we describe (1), there is a huge concentration of this previously unidentified blue protein that binds biliverdin. In the frog, it was a mystery. How can the animals have such huge concentrations of biliverdin? The physiology of that was weird because in …
You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.